Navidea Biopharmaceuticals Inc organizacji EPS Q/Q
Jaka jest wartość EPS Q/Q organizacji Navidea Biopharmaceuticals Inc?
Wartość EPS Q/Q organizacji Navidea Biopharmaceuticals Inc to -38.46%
Jaka jest definicja EPS Q/Q?
Perspektywiczna kwartalna stopa wzrostu (Quarterly EPS growth rate) to szacowany wzrost wartości EPS w ujęciu kwartalnym za ostatnie cztery kwartały w porównaniu z wynikami z ostatnich czterech kwartałów.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q firm w Health Care sektor na NYSEMKT w porównaniu do Navidea Biopharmaceuticals Inc
Czym się zajmuję organizacja Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Firmy z eps q/q podobne do Navidea Biopharmaceuticals Inc
- Wartość EPS Q/Q organizacji Akzo Nobel NV to -38.71%
- Wartość EPS Q/Q organizacji Aeglea BioTherapeutics Inc to -38.71%
- Wartość EPS Q/Q organizacji InflaRx N.V to -38.71%
- Wartość EPS Q/Q organizacji GE Aerospace to -38.60%
- Wartość EPS Q/Q organizacji Semler Scientific to -38.55%
- Wartość EPS Q/Q organizacji First Foundation Inc to -38.55%
- Wartość EPS Q/Q organizacji Navidea Biopharmaceuticals Inc to -38.46%
- Wartość EPS Q/Q organizacji J&J Snack Foods to -38.41%
- Wartość EPS Q/Q organizacji Stemline Therapeutics to -38.36%
- Wartość EPS Q/Q organizacji Black Diamond Therapeutics Inc to -38.14%
- Wartość EPS Q/Q organizacji AngloGold Ashanti Plc to -38.10%
- Wartość EPS Q/Q organizacji Franklin Resources to -38.10%
- Wartość EPS Q/Q organizacji Allena Pharmaceuticals Inc to -38.10%